J. A. Paixão

Synthesis, Structure, and Antileishmanial Activity of Novel 1,2,4‐Trioxolanes, 1,2,4,5‐Tetraoxanes and Their Respective Deoxygenated Controls

Given the reluctance of pharmaceutical companies to invest in new antileishmanial drugs, due to high costs and low perspectives of financial return, there is growing interest in repurposing existing drugs, often a more cost‐effective and quicker strategy to launch effective therapeutic solutions. Artemisinins, used as...